Best Cscc Podcasts (2025)

1
JCO at ASCO Annual Meeting: Avelumab Plus Cetuximab vs. Avelumab in Advanced cSCC 8:42

Play Pause

14d ago8:42

8:42

JCO Editorial Fellow Dr. Ece Cali Daylan and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2025 Simultaneous Publication paper "A Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab vs. Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma (cSCC)." Transcript The guest on this podcast episode has no disclosures…

1
Transformation Happens... when I embrace the love of Jesus. 24:30

21d ago24:30

24:30

By Josh Fisher

1
JCO at ASCO Annual Meeting: Neoadjuvant Osimertinib for Resectable EGFR-Mutated NSCLC 6:54

12d ago6:54

6:54

JCO Editorial Fellow Dr. Ece Cali Daylan and JCO Associate Editor Dr. Thomas Stinchcombe discuss the ASCO 2025 Simultaneous Publication paper "Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small-Cell Lung Cancer." Transcript The guest on this podcast episode has no disclosures to declare. Dr. Ece Cali: Hello, and welcome to our 2025 ASCO …

1
JCO at ASCO Annual Meeting: Use of Low-Value Cancer Treatments in Medicare 8:17

14d ago8:17

8:17

JCO Editorial Fellow Dr. Lauren Shih and JCO Associate Editor Dr. Stephanie Wheeler discuss the ASCO 25 Simultaneous Publication paper "Use of Low-Value Cancer Treatments in Medicare Advantage Versus Traditional Medicare." Transcript The guest on this podcast episode has no disclosures to declare. Dr. Lauren Shih: Hello, and welcome to our 2025 ASC…

1
JCO at ASCO Annual Meeting: Lenvatinib Plus Pembrolizumab and Chemotherapy in Gastric Cancer 6:52

14d ago6:52

6:52

JCO Editorial Fellow Dr. Peter Li and JCO Associate Editor Dr. Andrew Ko discuss the ASCO 25 Simultaneous Publication paper "Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III Randomized LEAP-015 Study." Transcript The guest on this podcast episode has no disclosu…

1
JCO at ASCO Annual Meeting: TTFields in Locally Advanced Pancreatic Adenocarcinoma 6:24

14d ago6:24

6:24

JCO Editorial Fellow Peter Li and JCO Associate Editor Eileen O'Reilly discuss the ASCO 25 Simultaneous Publication paper "Tumor-Treating Fields with Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal, Phase 3 PANOVA-3 Study." Transcript The guest on this podcast episode has no disclosures…

1
JCO Article Insights: Double Hit Myeloma Correlates With Adverse Patient Outcome 15:50

16d ago15:50

15:50

In this JCO Article Insights episode, host Michael Hughes summarizes "Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma" by Kaiser et al, published February 18, 2025, followed by an interview with JCO Associate Editor Suzanne Lentzsch. Transcript Michael Hughes: Welcome to t…

1
Transformation Happens... The Exodus Way 27:56

28d ago27:56

27:56

By Mark Schearer

1
Transformation Happens... When I Show Up 30:05

1M ago30:05

30:05

By Josh Fisher

1
Pembrolizumab and Bevacizumab for Melanoma Brain Metastases 23:59

1M ago23:59

23:59

Host Dr. Davide Soldato and guest Dr. Harriet Kluger discuss the JCO article "Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases." Transcript The guest on this podcast episode has no disclosures to declare. Dr. Davide Soldato Hello and welcome to JCO After Hours, the podcast where we sit down wit…

1
Transformation Happens 28:07

1M ago28:07

28:07

By Becca Riddle

1
JCO Article Insights: ESPAC4 Long-Term Follow-Up in Pancreatic Cancer 6:47

2M ago6:47

6:47

In this JCO Article Insights episode, host Joseph Mathew summaries Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial, by Palmer, et al published December 5, 2024. Transcript Joseph Mathew: Hello and welcome to the Journal of Clinical Oncology Article Insights. I'm your host, Joseph Mathew, and today we …

1
Special Guest Speaker Craig Fowler 43:28

2M ago43:28

43:28

By Craig and Allison Fowler

1
Easter Sunday 2025 51:05

2M ago51:05

51:05

By Josh Fisher

1
Good News for the Forgiven 32:05

2M ago32:05

32:05

By Mark Schearer

1
Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment 26:50

2M ago26:50

26:50

Host Dr. Davide Soldato and guests Dr. Jessica Burris discuss the article "Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment in American College of Surgeons Accredited Cancer Programs" and how persistent smoking following cancer diagnosis causes adverse outcomes while smoking cessation can improve su…

1
Good News for the Spiritually Oppressed 31:09

2M ago31:09

31:09

By Josh Fisher

1
JCO Article Insights: Smoking Assessment 8:35

3M ago8:35

8:35

In this JCO Article Insights episode, Lauren Shih summaries "Longitudinal Results From the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment in American College of Surgeons–Accredited Cancer Programs" by Jessica L. Burris, et al published November 19, 2024. Come back for the next episode where JCO After Hours host, Dr. Davide Sol…

1
Good News for Sinners Like Me 33:18

3M ago33:18

33:18

By Becca Riddle

1
Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cH 14:53

3M ago14:53

14:53

(FRENCH) In this podcast episode, which follows this introduction in French, Dr Christopher Lemieux summarizes a paper by Dr Abramson, et al. on the management of Peripheral Neuropathy Associated with Brentuximab Vedotin in the Frontline Treatment of classical Hodgkin Lymphoma. Our Guest Dr Lemieux is a Hematologist at the Centre hospitalier univer…

1
Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL 19:42

3M ago19:42

19:42

In this podcast episode, Dr. Michael Chu discusses the management of peripheral neuropathy associated with the use of brentuximab vedotin for the first-line treatment of classical Hodgkin Lymphoma. Our Guest Dr. Michael Chu is a clinician scientist at the Cross Cancer Institute and an Associate Professor at the University of Alberta in Edmonton, Al…

1
Guest Speaker Keith Potter (Single topic sermon) 31:50

3M ago31:50

31:50

By Guest Speaker

5M ago25:43

25:43

Host Dr. Davide Soldato and his guests Dr. Ann Wu and Dr. Alexa White discuss the article "Air Pollution and Breast Cancer Incidence in the Multiethnic Cohort Study" and the editorial "Growing Evidence for the Role of Air Pollution in Breast Cancer Development" TRANSCRIPT The guests on this podcast episode have no disclosures to declare. Dr. Davide…